Advisory Board and Editors Dermatology
Bruno Fionda
Dr. Fionda graduated in Medicine and Surgery and subsequently specialized in Radiotherapy at the Catholic University of the Sacred Heart in Rome. He started working in 2016 at Gemelli-ART (Advanced Radiation Therapy) in Rome dealing with special techniques, such as Surface Guided Radiotherapy (SGRT) which uses specific light sources to monitor the patient’s surface during therapy. Dr. Fionda worked with the first hybrid machine installed in Italy that combines modern linear accelerators (LINAC) with the acquisition of magnetic resonance images allowing to follow the movement of the internal organs in real time. He has also gained long experience in interventional radiotherapy (brachytherapy) with both high dose rate (HDR) and pulsed dose rate (PDR).
Dr Fionda is a member of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) and of the European Society for Radiotherapy and Oncology (ESTRO). He is the author of over 100 publications including conference abstracts and research articles on national and international journals, and is adjunct Professor of Radiation Oncology at Saint Camilus International University of Healh Sciences.
Ana Maria Jimenez-Cebrian
Dr. Ana Maria Jimenez-Cebrian is a Professor within the Department of Nursing and Podiatry at the University of Malaga.
Her primary research areas focus on Confirmatory Factor Analysis, Anthropometrics, Musculoskeletal, Childhood, Gait and Walking.
Tarl W Prow
Dr. Tarl Prow is the Deputy Director of the Dermatology Research Centre within the School of Medicine and heads a group of 10 researchers focused on micromedical devices for dermatology and nanomedicine. He is a multidisciplinary researcher with internationally recognized expertise in the fields of micro-medical device development, nanodermatology, topical drug delivery and non-invasive imaging.
Mansour Sobeh
Mansour Sobeh holds a B.Sc. in Chemistry from Ain Shams University, Egypt, an M.Sc. in Analytical Chemistry from the German University in Cairo, Egypt, and a Ph.D. in Natural Sciences (Dr. rer. nat.) from Heidelberg University, Germany. He is currently an Assistant Professor at Mohammed VI Polytechnic University
Mitchell S Stark
For the past 20 years I have been actively working in the field of melanoma and naevi genomics. I have worked and performed my PhD candidature based at the QIMR Berghofer Medical Research Institute (1999-2015) and in 2015 I relocated as a Research Fellow in the Dermatology Research Centre, The University of Queensland Diamantina Institute. Over this time I have been working towards understanding the aetiology of melanoma, studying gene dysregulation during tumour progression along with predisposition to melanoma in families with high risk for melanoma development. My research group (genomics and miRNA biomarker discovery) based within the Dermatology Research Centre (UQDI) is currently engaged in miRNA biomarker and genomics research for early detection in melanoma, skin cancer (SCC), as well as non-small cell lung cancer.
Guangdong Yang
Dr. Yang’s research focuses on a group of gasotransmitters, especially H2S, in the regulation of cellular functions and human diseases. Dr. Yang has received numerous awards and recognitions, including New Investigator award from the Heart and Stroke Foundation of Canada and Maureen Andrew Award from Heart and Stroke Foundation of Ontario. In his career, Dr. Yang has published ~100 peer-reviewed research articles, some of them published in high-impact journals, including as Science, Circulation, PNAS, and EMBO report etc. Their total citations are 7,481 (September 24, 2018).